Stock search

Ticker or company name

PFE card

PFE price forecast

Pfizer$28,86

P/E now is 41,2. Average over 5 years: 20,3 (range 10–20). The stock is 104% above its history.

Base · FY2030

$57,15+24,1% a year

The base case gives 24,1% a year, above your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$67,9 bn$73,6 bn$79,9 bn$86,7 bn$94,0 bn
Net income$11,8 bn$12,8 bn$13,9 bn$15,1 bn$16,4 bn
EPS$2,06$2,23$2,41$2,61$2,82

Changed values are highlighted. Bear and bull cases: growth ∓ 50%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $28,86

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$1,12

Price change
−96,1%
A year
−43,2%
Fair value today
$1,90
Margin of safety
−93,4%

Base$57,15

Price change
+98,0%
A year
+24,1%
Fair value today
$47,40
Margin of safety
+64,2%

Bull$422,45

Price change
+1 363,8%
A year
+98,2%
Fair value today
$326,52
Margin of safety
+1 031,4%

What growth the price implies

For the stock to return 10% a year, revenue must grow 2,4% a year to FY2030 at a 17,4% margin and P/E 20,3.

Growth over 5 years
8,5%
Analyst consensus
no data
In your model
8,5%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$57,15+24,1% a year